PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 12, 2024Nature Communications22 citationsOpen Access

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma

View Full Paper

Authors

SSStephan SpahnFKFabian KleinhenzESEkaterina Shevchenko

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Spahn et al. (2024) studied this question.

synapsesocial.com/papers/68e796dbb6db643587707c28https://doi.org/10.1038/s41467-024-45247-6
Ask AI
Helpful
Bookmark
Share
View Full Paper